ANTITHROMBOTIC EFFECT OF RECOMBINANT TRUNCATED TISSUE FACTOR PATHWAY INHIBITOR (TFPI(1-161) IN EXPERIMENTAL VENOUS THROMBOSIS - A COMPARISON WITH LOW-MOLECULAR-WEIGHT HEPARIN - A RANDOMIZED DOUBLE-DUMMY STUDY IN RABBITS
J. Holst et al., ANTITHROMBOTIC EFFECT OF RECOMBINANT TRUNCATED TISSUE FACTOR PATHWAY INHIBITOR (TFPI(1-161) IN EXPERIMENTAL VENOUS THROMBOSIS - A COMPARISON WITH LOW-MOLECULAR-WEIGHT HEPARIN - A RANDOMIZED DOUBLE-DUMMY STUDY IN RABBITS, Thrombosis and haemostasis, 69(6), 1993, pp. 888-888